| Lena Ai Nhi Nguyen, PHARMD | |
|
3333 Masonic Dr, Alexandria, LA 71301-3842 | |
| (318) 445-6386 | |
| Not Available |
| Full Name | Lena Ai Nhi Nguyen |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3333 Masonic Dr, Alexandria, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154966612 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PST.023184 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lena Ai Nhi Nguyen, PHARMD 3333 Masonic Dr, Alexandria, LA 71301-3842 Ph: (318) 445-6386 | Lena Ai Nhi Nguyen, PHARMD 3333 Masonic Dr, Alexandria, LA 71301-3842 Ph: (318) 445-6386 |
News Archive
Researchers Sandro Galea from the Boston University School of Public Health, Boston, Raina M. Merchant, from the Perelman School of Medicine, Philadelphia, and Nicole Lurie, from the Coalition for Epidemic Preparedness Innovations. Oslo, Norway, published an opinion paper in the JAMA Internal Medicine titled, "The Mental Health Consequences of COVID-19 and Physical Distancing The Need for Prevention and Early Intervention".
A study published now on Nature Communications shows that breast cancer cells undergo a stiffening state prior to acquiring malignant features and becoming invasive.
Baxter International Inc. has entered into a definitive agreement to acquire Gambro AB, a privately held dialysis product company based in Lund, Sweden, for total consideration of 26.5 billion SEK (approximately $4.0 billion USD at current exchange rates).
A new study has laid bare the structure of a protein receptor called the CysLT1 receptor that is implicated in a range of allergic and cardiovascular conditions as well as some types of cancer. Published in Science Advances, the paper shows how the researchers used structural biology techniques to accomplish this feat.
Clovis Oncology, Inc. announced today that the first clinical study of CO-1686 has commenced with the dosing of the first patient at a U.S. study site. CO-1686 is a novel, oral, targeted covalent inhibitor of epidermal growth factor receptor (EGFR) mutations currently being studied for the treatment of non-small cell lung cancer.
› Verified 9 days ago
Bonnie Cobb, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2050 N Mall Dr, Alexandria, LA 71301 Phone: 318-445-4305 | |
Abiy Asfaw, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 54450 Provine Pl, Alexandria, LA 71303 Phone: 207-907-8449 | |
Kelsie Connolly, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3333 Masonic Dr, Alexandria, LA 71301 Phone: 318-445-6386 | |
Darla Corley, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1414 Jackson St, Alexandria, LA 71301 Phone: 318-445-5358 | |
Miss Tuyet Thi Tran, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 219 Macarthur Dr, Alexandria, LA 71303 Phone: 318-473-2895 | |
Jill Ford, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 604 Macarthur Dr, Alexandria, LA 71303 Phone: 318-442-5710 Fax: 318-442-4487 | |
Mr. Louis Cataldie Iv, RPH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Va Medical Center Alexandria, Alexandria, LA 71306 Phone: 318-473-0010 Fax: 318-473-5020 |